Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments -- Ignore unavailable to you. Want to Upgrade?

To: chummer who wrote (35)	8/1/2014 3:05:22 PM
From: statesidereport	Respond to of 608

I'm in the states so I can buy CONX easily through TD Ameritrade and Etrade - I get a bid and ask on the US side. TKM (Canada) also trades on Nasdaq so you can buy it in Canada or the US (including options). I like CONX for the leverage. They are profitable, earning revenues, no debt, and just got a $2.9 million grant from the NIH (equivalent of Health Canada). This ebola thing will be around into next year so there is plenty of time for it to run - once people start realizing this won't fizzle out. It's amazing looking at all the investment boards in the US and Canada that NO ONE is talking about CONX. It tells me it will run hard when it gets "noticed". stateside